Applied DNA Sciences, Inc. (BNBX) filed an 8-K on November 4, 2025, reporting two material events: an At The Market (ATM) Offering Agreement and a strategic executive consulting appointment.
Capital Markets Activity (ATM Offering) The Company entered an ATM Offering Agreement with Lucid Capital Markets, LLC, dated November 4, 2025, to potentially sell up to $8,157,932 in common stock shares. Sales will occur “at the market” under the existing Form S-3 shelf registration (File No. 333-272267), effective for the Nasdaq Capital Market. The Manager receives a 3% commission per sale. T
...